Engineered to Lead the Saliva Collection Market in Molecular Diagnostic Applications
The SDNA-1000 offers single device integration for both DNA and viral RNA applications. Spectrum’s CV3 patented blue preservation chemistry is 100% bacteriostatic delivering 100% inactivation of the live virus providing the most robust and safest biomaterial collection approach for the detection and diagnosis of disease or infection.
Spectrum reduces sample self-collection errors with its intuitive product design for those offering direct-to-patient diagnostic testing or teams that may have experienced clinical study or project failures from sample self-collection errors of the past.
The SDNA saliva collection device additionally offers over 10 days of post-collection stability with no degradation of sample efficacy and ships with verified, unique barcode serialization for biosample physical and digital chain-of-custody. Additionally, customized packaging, kitting, and fulfillment options are available to solve any special project or testing workflow requirements.
For many, choosing the wrong saliva collection device has introduced, and often increased critical failure points. Spectrum’s new and technically-superior saliva collection device is the answer your teams and projects have been waiting for.
The first saliva collection device to be authorized for COVID-19 testing, the SDNA-1000 was shown to be a robust source of viral RNA and proven to deliver a safer and more accurate testing sample when compared to traditional swabbing.
Engineered to Lead the Saliva Collection Market in Molecular Diagnostic Applications.
The SDNA-1000 offers single device integration for both DNA and viral RNA applications. Spectrum’s CV3 patented blue preservation chemistry is 100% bacteriostatic delivering 100% inactivation of the live virus providing the most robust and safest biomaterial collection approach for the detection and diagnosis of disease or infection.
Spectrum reduces sample self-collection errors with its intuitive product design for those offering direct-to-patient diagnostic testing or teams that may have experienced clinical study or project failures from sample self-collection errors of the past.
The SDNA saliva collection device additionally offers over 10 days of post-collection stability with no degradation of sample efficacy and ships with verified, unique barcode serialization for biosample physical and digital chain-of-custody. Additionally, customized packaging, kitting, and fulfillment options are available to solve any special project or testing workflow requirements.
For many, choosing the wrong saliva collection device has introduced, and often increased critical failure points. Spectrum’s new and technically-superior saliva collection device is the answer your teams and projects have been waiting for.
The first saliva collection device to be authorized for COVID-19 testing, the SDNA-1000 was shown to be a robust source of viral RNA and proven to deliver a safer and more accurate testing sample when compared to traditional swabbing.
SDNA-1000 is ideal for commercial bioinformatic DNA testing applications, academic, research, biobanking, and as a biosample collection option for viral DNA/RNA COVID-19 testing for hospital networks, health departments, and clinical research organizations. Find additional documentation.
SDNA-2000 is used for medical device collections of high-quality saliva-based DNA samples used for molecular diagnostics.
Product, Process, & Regulatory Documentation
Find the most current and available product, process, and regulatory documentation below. Don’t see what your looking for? Please contact us for access to additional information. Click here for additional study and proof-point information.
Product, Process, & Regulatory Documentation
Find the most current and available product, process, and regulatory documentation below. Don’t see what your looking for? Please contact us for access to additional information. Click here for additional study and proof-point information.
Intuitive Design
on Purpose
on Purpose
User collection error is one of the most common points of failure from saliva self-collection.
So we engineered the solution.
A whole saliva collection device shown to be so intuitive that even without instructions, biosamples are still collected correctly.
WE RECOMMEND: Do not eat, drink, chew gum, or smoke at least 30 minutes before spitting into SDNA-1000 saliva collection tube.
Painless, more accurate, and safer COVID-19 testing using saliva
The SDNA-1000 is the first saliva collection device FDA authorized for COVID-19 diagnostic testing and analysis. The pioneering innovation of the SDNA-1000 and its growing list of benefits are not only leading the way to a new era of at-home biosample self-collection for the diagnosis of viral infections, but studies have also shown when using saliva for molecular analysis the essential step of extraction and purification delivers the needed sensitivity boost required for optimal accuracy. Learn more by exploring the Rutgers 100% positive agreement saliva vs. swab COVID-19 testing study and others here.
- Single device for both DNA & viral RNA applications
- 100% Inactivation of the live virus within the device at ambient temps
- Safest & most robust biomaterial for detecting COVID-19
- Over 10 days of post-collection stability with no degradation of sample efficacy
- Painless collection system maintains biosample consistency
- Mitigates any risk of infection throughout the testing process
- Pinpoint life-cycle stage of active viral infection
- Qualified commercial RNA extraction chemistries include Perkin Elmer, Thermo Fisher, Roche, Qiagen, and more
Painless, more accurate, and safer COVID-19 testing using saliva.
The SDNA-1000 is the first saliva collection device FDA authorized for COVID-19 diagnostic testing and analysis. The pioneering innovation of the SDNA-1000 and its growing list of benefits are not only leading the way to a new era of at-home biosample self-collection for the diagnosis of viral infections, but studies have also shown when using saliva for molecular analysis the essential step of extraction and purification delivers the needed sensitivity boost required for optimal accuracy. Learn more by exploring the Rutgers 100% positive agreement saliva vs. swab COVID-19 testing study and others here.
- Single device for both DNA & viral RNA applications
- 100% Inactivation of the live virus within the device at ambient temps
- Safest & most robust biomaterial for detecting COVID-19
- Over 10-days of post-collection stability with no degradation of sample efficacy
- Painless collection system maintains biosample consistency
- Mitigates any risk of infection throughout the testing process
- Pinpoint life-cycle stage of active viral infection
- Qualified commercial RNA extraction chemistries include Perkin Elmer, Thermo Fisher, Roche, Qiagen, and more
How-To Product
Video Tour
Video Tour
Huge amounts of innovative engineering developed a saliva collection device so simple and easy to use, it has been rewriting biosample collection protocols across the nation and worldwide. The intuitive design and minimal steps are a welcomed answer for those that have suffered clinical study and project failures due to self-collection errors and the lack of device options prior to Sprecturm’s new SDNA solution.
How-To Product
Video Tour
Video Tour
Huge amounts of innovative engineering developed a saliva collection device so simple and easy to use, it has been rewriting biosample collection protocols across the nation and worldwide. The intuitive design and minimal steps are a welcomed answer for those that have suffered clinical study and project failures due to self-collection errors and the lack of device options prior to Sprecturm’s new SDNA solution.
What does technically superior mean?
What does technically superior mean?
Solution for Self-Collection Errors
Proof-PointSignificantly Reduce Most Common Sources of User Error
Spectrum’s whole saliva collection device addresses the three most common sources of user error, with easy-to-understand instructions and intuitive device design.
[User study coming soon]
100% Bacteriostatic Chemistry
Proof-PointSDNA Breaks Down Collected Bacteria While Inhibiting New Growth
Spectrum’s whole saliva collection device delivers a cleaner DNA sample and reduces variability, resulting in increased reproducibility, fewer sample failures, and less frequent bacterial misreads.
[White paper coming soon]
Is it COVID-19? The Flu? H1N1? or...
Proof-PointAt-Home Saliva Collection Offers Easy Answers
Over-engineered on purpose to solve genetic testing and molecular diagnostic industry pain-points, the SDNA-1000 is leading the way to a new era of at-home biosample self-collection for the diagnosis of different viral infections.
[White paper coming soon]
Device Inactivates COVID-19 Virus
Proof-PointSafer, Pain-free, & more Accurate
The inactivation of the virus in the SDNA-1000 saliva collection device creates the most robust and safest biomaterial collection approach for the detection of COVID-19 infections and leads the way to a new era of at-home biosample self-collection for the diagnosis of viral infections.
Saliva is a Better Biosample for Detecting Infection
Proof-PointStudies Echo Rutgers Significant Saliva Findings
Understanding the breakthrough discovery saliva has delivered goes far beyond expanding COVID-19 testing options. It offers the safest & most robust biomaterial for detecting viral infections and mitigates any risk of infection throughout the entire testing process.
Saliva Sample Viability Transport Study
Proof-PointTested in extreme hot and cold temperatures
FDA Expands current EUA to include the at-home collection of saliva samples for COVID-19 testing. Direct-to-patient at-home collection adds testing complexity and risks sample consistency, sample viability, and sample stability. See the stats and specifics behind the FDA EUA authorization.
Solution for Self-Collection Errors
Proof-PointSignificantly Reduce Most Common Sources of User Error
Spectrum’s whole saliva collection device addresses the three most common sources of user error, with easy-to-understand instructions and intuitive device design.
[User study coming soon]
100% Bacteriostatic Chemistry
Proof-PointSDNA Breaks Down Collected Bacteria While Inhibiting New Growth
Spectrum’s whole saliva collection device delivers a cleaner DNA sample and reduces variability, resulting in increased reproducibility, fewer sample failures, and less frequent bacterial misreads.
[White paper coming soon]
Is it COVID-19? The Flu? H1N1? or...
Proof-PointAt-Home Saliva Collection Offers Easy Answers
Over-engineered on purpose to solve genetic testing and molecular diagnostic industry pain-points, the SDNA-1000 is leading the way to a new era of at-home biosample self-collection for the diagnosis of different viral infections.
[White paper coming soon]
Device Inactivates COVID-19 Virus
Proof-PointSafer, Pain-free, & more Accurate
The inactivation of the virus in the SDNA-1000 saliva collection device creates the most robust and safest biomaterial collection approach for the detection of COVID-19 infections and leads the way to a new era of at-home biosample self-collection for the diagnosis of viral infections.
Saliva is a Better Biosample for Detecting Infection
Proof-PointStudies Echo Rutgers Significant Saliva Findings
Understanding the breakthrough discovery saliva has delivered goes far beyond expanding COVID-19 testing options. It offers the safest & most robust biomaterial for detecting viral infections and mitigates any risk of infection throughout the entire testing process.
Saliva Sample Viability Transport Study
Proof-PointTested in extreme hot and cold temperatures
FDA Expands current EUA to include the at-home collection of saliva samples for COVID-19 testing. Direct-to-patient at-home collection adds testing complexity and risks sample consistency, sample viability, and sample stability. See the stats and specifics behind the FDA EUA authorization.